New COPD inhaler shows promise in quick lung function boost
NCT ID NCT06545500
First seen Feb 12, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested three doses of an inhaled medicine called glycopyrrolate in 46 adults with COPD. Each person received the medicine or a placebo for one week at a time. The goal was to see if the medicine improved lung function and was safe. The trial is complete, and results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Health Research Inc
Charlotte, North Carolina, 28277, United States
-
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida, 33765, United States
-
Clinical Research of West Florida Inc - Tampa
Tampa, Florida, 33606, United States
-
Midwest Chest Consultants PC
Saint Charles, Missouri, 63301, United States
-
Velocity Clinical Research - Greenville
Greenville, South Carolina, 29615, United States
-
Velocity Clinical Research - Spartanburg
Spartanburg, South Carolina, 29303, United States
-
Velocity Clinical Research - Union
Union, South Carolina, 29379, United States
Conditions
Explore the condition pages connected to this study.